L-Methylfolate as a Monotherapy for Treatment-Resistant Depression: A Case Study

Carrie Baldwin-Sayre, ND; Angela Hardin, ND

This case study examines a 49-year-old Asian American female patient with long-standing fatigue and depression (20 years or more), for which pharmaceutical antidepressant therapies have been ineffective. History, physical examination, laboratory tests, and Genomind Genecept Assay genetic testing were used to determine symptom severity, investigate the presence of organic causes of fatigue, and provide a potential novel monotherapy for depression. Therapeutic intervention included a slow titration of L-methylfolate to an eventual therapeutic daily dose of 15 mg.

I am a subscriber to IMCJ and would like to read this article
I would like to purchase this article - $35.00
I would like to subscribe to IMCJ for $55.00 and obtain access to this article